Congress

Last month, the World Generic Medicines Congress Americas held its annual conference in Washington, DC. The conference was…

Last year Senator Charles Grassley (R-Iowa) asked for proof that the purchasing intermediaries that buy medical products for…

With much of the United States suffering from shortages of primary care physicians, especially in rural regions, nurse…

Before the Senate left DC earlier this month, the U.S. Senate Committee on Commerce, Science and Technology held a hearing…

 Recently, Senator Al Franken (D-MN) called on Congress to create extra incentives for medical device makers to tackle rare…

Last week, the Wall Street Journal reported on documents submitted to Congress (though it is unclear who in congress requested…

Although the health care overhaul included some pricing transparency, the provision was not enough transparency for Representative…

In response to the controversy created by diabetes drug Avandia (GlaxoSmithKline), the House Appropriations Subcommittee on…

Last month during the health care debate, the Senate Special Committee on Aging held an informational session (hearings were…

Last year, a report by the Department of Health and Human Services (HHS) Office of the Inspector General (OIG), noted that “the US…